Andrew Love Cancer Centre, Deakin University, Geelong Hospital, Royal Melbourne Hospital
This person has declared the following competing interest:
Received sponsorship from Roche, Novartis and Sanofi-Aventis to attend scientific meetings.
Received a grant from Merck Serono to conduct a clinical trial.
Involved as a consultant and in an advisory capacity by Roche.
Nature of input: appraised literature regarding role of chemotherapy in stage IV lung cancer.